Literature DB >> 6299143

Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus.

N C Pedersen, J W Black.   

Abstract

Kittens vaccinated with an avirulent biotype of the Black strain of feline infectious peritonitis virus (FIPV; given oronasally) developed both indirect fluorescent and virus-neutralizing antibodies, but were not protected against oronasal challenge exposure with virulent virus. In fact, kittens vaccinated with avirulent virus were more readily infected than were nonvaccinated cats. A proportion of kittens could be immunized to FIPV by giving sublethal amounts of virulent virus. This technique, however, was too inconsistent and hazardous to have clinical relevance. The results of these studies indicated that humoral immunity was not protective in FIPV infection. There was no correlation between fluorescent and virus-neutralizing antibodies and either disease or immunity. Immune serum from FIPV-resistant cats failed to passively protect susceptible animals against virulent virus given intraperitoneally or oronasally, and as expected, actually sensitized them to infection. It was concluded that cell-mediated immunity was probably responsible for protection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299143

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  56 in total

1.  Possible immunoenhancement of persistent viremia by feline leukemia virus envelope glycoprotein vaccines in challenge-exposure situations where whole inactivated virus vaccines were protective.

Authors:  N C Pedersen; L Johnson; D Birch; G H Theilen
Journal:  Vet Immunol Immunopathol       Date:  1986-02       Impact factor: 2.046

2.  Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets.

Authors:  Hana Weingartl; Markus Czub; Stefanie Czub; James Neufeld; Peter Marszal; Jason Gren; Greg Smith; Shane Jones; Roxanne Proulx; Yvonne Deschambault; Elsie Grudeski; Anton Andonov; Runtao He; Yan Li; John Copps; Allen Grolla; Daryl Dick; Jody Berry; Shelley Ganske; Lisa Manning; Jingxin Cao
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 3.  Animal virus infections that defy vaccination: equine infectious anemia, caprine arthritis-encephalitis, maedi-visna, and feline infectious peritonitis.

Authors:  N C Pedersen
Journal:  Adv Vet Sci Comp Med       Date:  1989

4.  Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus.

Authors:  W V Corapi; C W Olsen; F W Scott
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

5.  Antigenic analysis of feline coronaviruses with monoclonal antibodies (MAbs): preparation of MAbs which discriminate between FIPV strain 79-1146 and FECV strain 79-1683.

Authors:  T Hohdatsu; T Sasamoto; S Okada; H Koyama
Journal:  Vet Microbiol       Date:  1991-06       Impact factor: 3.293

6.  Genome organization and reverse genetic analysis of a type I feline coronavirus.

Authors:  Gergely Tekes; Regina Hofmann-Lehmann; Iris Stallkamp; Volker Thiel; Heinz-Jürgen Thiel
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

Review 7.  Topics in feline neurology.

Authors:  L A Nafe
Journal:  Vet Clin North Am Small Anim Pract       Date:  1984-11       Impact factor: 2.093

Review 8.  Feline infectious peritonitis. An immune-mediated coronaviral vasculitis.

Authors:  J R August
Journal:  Vet Clin North Am Small Anim Pract       Date:  1984-09       Impact factor: 2.093

Review 9.  Coronavirus infection in cats.

Authors:  J D Hoskins
Journal:  Vet Clin North Am Small Anim Pract       Date:  1993-01       Impact factor: 2.093

Review 10.  Dengue hemorrhagic fever in infants: research opportunities ignored.

Authors:  Scott B Halstead; Nguyen Trong Lan; Thein Thein Myint; Than Nu Shwe; Ananda Nisalak; Siripen Kalyanarooj; Suchitra Nimmannitya; Soegeng Soegijanto; David W Vaughn; Timothy P Endy
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.